Sabrina Corlette, J.D., and Christine H. Monahan, J.D.
doi : 10.1056/NEJMp2206049
Vol. 387 No. 25
Elizabeth P. Griffiths, M.D., M.P.H.
doi : 10.1056/NEJMp2209203
Alik Farber, M.D., Matthew T. Menard, M.D., Michael S. Conte, M.D., John A. Kaufman, M.D., Richard J. Powell, M.D., Niteesh K. Choudhry, M.D., Ph.D., Taye H. Hamza, Ph.D., Susan F. Assmann, Ph.D., Mark A. Creager, M.D., Mark J. Cziraky, Pharm.D., Michael D. Dake, M.D., Michael R. Jaff, D.O.,
doi : 10.1056/NEJMoa2207899
Patients with chronic limb-threatening ischemia (CLTI) require revascularization to improve limb perfusion and thereby limit the risk of amputation. It is uncertain whether an initial strategy of endovascular therapy or surgical revascularization for CLTI is superior for improving limb outcomes.
Evan S. Dellon, M.D., M.P.H., Marc E. Rothenberg, M.D., Ph.D., Margaret H. Collins, M.D., Ikuo Hirano, M.D., Mirna Chehade, M.D., M.P.H., Albert J. Bredenoord, M.D., Ph.D., Alfredo J. Lucendo, M.D., Ph.D., Jonathan M. Spergel, M.D., Ph.D., Seema Aceves, M.D., Xian Sun, Ph.D., Matthew P. Kosloski, Ph.D., Mohamed A. Kamal, Pharm.D., Ph.D.,
doi : 10.1056/NEJMoa2205982
Dupilumab, a fully human monoclonal antibody, blocks interleukin-4 and interleukin-13 signaling, which have key roles in eosinophilic esophagitis.
Bern-Thomas Nyang’wa, M.B., B.S., Catherine Berry, B.Med., Emil Kazounis, M.Med.Sci., Ilaria Motta, Ph.D., Nargiza Parpieva, Sc.D., Zinaida Tigay, M.D., Varvara Solodovnikova, M.D., Irina Liverko, Sc.D., Ronelle Moodliar, M.B., B.S., Matthew Dodd, M.Sc., Nosipho Ngubane, M.B., B.Ch., Mohammed Rassool, M.B., B.Ch.,
doi : 10.1056/NEJMoa2117166
In patients with rifampin-resistant tuberculosis, all-oral treatment regimens that are more effective, shorter, and have a more acceptable side-effect profile than current regimens are needed.
Morton J. Cowan, M.D., Jason Yu, Ph.D., Janelle Facchino, P.N.P., Carol Fraser-Browne, B.A., Ukina Sanford, M.S., Misako Kawahara, B.A., Jasmeen Dara, M.D., Janel Long-Boyle, Pharm.D., Ph.D., Jess Oh, M.S., Wendy Chan, B.S., Shivali Chag, M.S., Lori Broderick, M.D., Ph.D.,
doi : 10.1056/NEJMoa2206575
The DNA-repair enzyme Artemis is essential for rearrangement of T- and B-cell receptors. Mutations in DCLRE1C, which encodes Artemis, cause Artemis-deficient severe combined immunodeficiency (ART-SCID), which is poorly responsive to allogeneic hematopoietic-cell transplantation.
Lars M. Asmis, M.D., Andreas Serra, M.D., Alexander Krafft, M.D., Abraham Licht, M.D., Elke Leisinger, M.D., Jana Henschkowski-Serra, M.D., Michael T. Ganter, M.D., Steffen Hauptmann, M.D., Marianne Tinguely, M.D., and Johanna A. Kremer Hovinga, M.D.
doi : 10.1056/NEJMoa2211113
Nadine S. Maalouf, M.D., and Meggie Morand, M.D.
doi : 10.1056/NEJMicm2207158
Sarah E. Little, M.D., M.P.H., Onofrio A. Catalano, M.D., Ph.D., Andrea G. Edlow, M.D., and Stuti G. Shroff, M.B., B.S., Ph.D.
doi : 10.1056/NEJMcpc2211363
Jonathan Golledge, M.Chir., F.R.A.C.S.
doi : 10.1056/NEJMe2214046
Alex Straumann, M.D.
doi : 10.1056/NEJMe2213030
Eric J. Rubin, M.D., Ph.D., Lindsey R. Baden, M.D., and Stephen Morrissey, Ph.D.
doi : 10.1056/NEJMe2216362
doi : 10.1056/NEJMc2210781
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟